Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStm Grp. Regulatory News (STM)

  • This share is currently suspended. It was suspended at a price of 61.50
  • There is currently no data for STM

Trading Update

30 Nov 2020 07:00

RNS Number : 8397G
STM Group PLC
30 November 2020
 

 

STM Group Plc

("STM" or "the Company" or "the Group")

Trading Update

 

STM, the cross-border financial services provider, today provides the following update on trading for the year ended 31 December 2020, and expectations for 2021 and beyond.

 

In line with current market expectations, the Board continues to expect the Group will deliver revenue of £23.7 million, EBITDA of £3.6 million, and £2.0 million profit before tax for the year to 31 December 2020.

 

The strong recurring revenue base from exisiting business gives the foundation for our future growth and profitability and remains predominantly unchanged despite the significant macro-economic challenges.

 

As part of the 2021 budget planning cycle, the Board has now taken the decision to adopt a more prudent methodology to its guidance for the year ending 31 December 2021 ("FY21") and beyond. This is set against a backdrop of on-going Covid-19 pandemic concerns, as well as very low interest rates and uncertainty in the financial markets. This has resulted in a number of changes to the assumptions being made, predominantly around new business.

 

The predictability and long-standing history of the QROP and company & trust businesses has meant that there are minimal changes to the Board's expectations of performance for these segments. Similarly, the Board has not changed its expectations for the auto-enrolment and flexible annuity products.

 

This revised approach primarily affects the level of new business for our life assurance and SIPP products.

 

In relation to the life assurance businesses, we have made the decision to not include any new policies from EU member states as a result of the continuing uncertainty surrounding Brexit, and what, if any, passporting rights Gibraltar will have after 2020 year-end. In addition, the Board has now assumed that no new short-term life annuities should be included in the Group's FY21 and FY22 expectations given these products are difficult to predict due to their long lead time. This is especially so in the current economic environment although the opportunity and product remain viable.

 

The Board has also now concluded that it would not be prudent to include any growth in the new business run rate for our expatriate SIPP revenue. Similarly, the Board is now assuming new UK SIPP business will be limited to current partnerships and introducers only, with a measured new business volume being generated by them and assuming no revenue from known but as yet untested partnerships.

 

Finally, the IT investments, as well as the acquisition accounting exercise carried out as per IFRS 3 on the Berkeley Burke acquisition earlier in the year, has resulted in an increased amortisation charge, a non-cash item that directly impacts our statutory profit before tax result.

 

We therefore now anticipate revenue growth of circa 7% for FY21 year-on-year, whilst operating expenses are only forecasted to increase marginally and thus enhanced EBITDA margins will be delivered. The improved EBITDA margin is largely as a result of both direct savings and increased operational efficiencies on the back of the IT projects invested in during the year. Further investment is expected in this area which has been reflected in the Board's revised financial expectations.

 

Alan Kentish, CEO of STM Group commented:

 

"The prolongued nature of the Covid-19 pandemic has had a more significant impact than we previously anticipated. This is frustrating but does not greatly affect the strong core existing business which gives us reliable revenue visibility and a stable long term platform to operate from.

 

"In light of previous challenges around new business, the Board has used the 2021 planning cycle to take a more prudent approach to our forward guidance, given the Covid-19 backdrop, Brexit and the various challenges faced by our introducer base.

 

"Notwithstanding the more prudent approach taken, we are confident in a step-change in profit growth for 2021, albeit from the lower rebased profit position for 2020. STM has a stable business model and a strong balance sheet so these short-term challenges, while unwelcome, require that we adjust our timescale not our ambition."

 

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

 

For further information, please contact:

STM Group Plc

www.stmgroupplc.com

Alan Kentish, Chief Executive Officer

Tel: Via Walbrook

Therese Neish, Chief Financial Officer

 

 

 

finnCap

www.finncap.com

Matt Goode / Emily Watts - Corporate Finance

Tim Redfern / Richard Chambers - ECM

Tel: +44 (0) 20 7220 0500

 

 

Walbrook

www.walbrookpr.com

Tom Cooper / Paul Vann

Tel: +44 (0) 20 7933 8780

 

Mob: +44 (0) 797 122 1972

 

tom.cooper@walbrookpr.com

 

 

Notes to editors:

 

STM is a multi-jurisdictional financial services group which is listed on the AIM Market of the London Stock Exchange. The Group specialises in the administration of client assets in relation to retirement, estate and succession planning and wealth structuring.

 

Today, the Group has operations in the UK, Gibraltar, Malta, Jersey and Spain. STM has developed a range of pension products for UK nationals and internationally domiciled clients and has two Gibraltar Life Assurance Companies which provide life insurance bonds - wrappers in which a variety of investments, including investment funds, can be held.

 

STM's growth strategy is focussed on both organic initiatives and strategic acquisitions.

 

Further information on STM Group can be found at www.stmgroupplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFZMZMLLVGGZM
Date   Source Headline
17th Mar 20152:00 pmRNSHolding(s) in Company
10th Mar 20157:02 amRNSFinal Results
9th Jan 20157:00 amRNSDirector Dealings/PDMR Shareholding
31st Dec 201410:59 amRNSDirectorate Change & Result of EGM
16th Dec 20147:00 amRNSDirector's Dealings/PDMR Shareholding
5th Dec 201410:00 amRNSNotice of EGM
9th Sep 20147:00 amRNSInterim Results
4th Jul 20147:00 amRNSDirector Dealings / Holdings in Company
21st May 201411:29 amRNSResult of AGM
15th May 20149:59 amRNSUpdate on Convertible Loan Notes
17th Apr 20147:00 amRNSAnnual Financial Report
11th Mar 20147:01 amRNSIssue of Convertible Loan Notes
11th Mar 20147:00 amRNS2013 Final Results
17th Jan 20147:00 amRNSDirectorate Change
23rd Dec 20137:00 amRNSStrategic & Trading Update
3rd Sep 20137:00 amRNSInterim Results
23rd Jul 20137:00 amRNSLaunch of new German life assurance product
17th Jul 20134:58 pmRNSHolding in Company
16th May 201311:32 amRNSResult of AGM
3rd May 20133:35 pmRNSAnnual Financial Report & AGM Notice
15th Mar 20132:56 pmRNSHoldings in Company
5th Mar 20137:00 amRNSFinal Results
18th Sep 20127:00 amRNSInterim Results
17th May 20123:02 pmRNSResult of AGM
18th Apr 201212:20 pmRNSAnnual Financial Report
13th Apr 20124:36 pmRNSIssue of Equity/Director Shareholding
9th Mar 20123:50 pmRNSIssue of Equity
6th Mar 20127:00 amRNSFinal Results
13th Feb 20125:08 pmRNSHolding in Company
13th Feb 20124:27 pmRNSHolding in Company
21st Dec 20117:37 amRNSTrading Update
27th Sep 201111:30 amRNSChange of director
20th Sep 20117:00 amRNSInterim Results
19th Sep 20117:00 amRNSChange of Adviser
1st Sep 20111:51 pmRNSHolding(s) in Company
13th May 20114:22 pmRNSDirectors Dealings
9th May 20117:00 amRNSAppointment of new Chairman
6th May 201110:59 amRNSResult of AGM
11th Apr 20114:12 pmRNSDirector/PDMR Shareholding
8th Apr 201112:00 pmRNSAnnual Report and Accounts and Notice of AGM
8th Mar 20117:00 amRNSPreliminary Results
17th Jan 20114:48 pmRNSHolding(s) in Company
7th Jan 20111:00 pmRNSDirector/PDMR Shareholding
17th Dec 20107:00 amRNSTrading Update
14th Dec 20107:00 amRNSBoard Changes and change of registered office
6th Oct 201010:45 amRNSIssue of Equity / Director Shareholding
15th Sep 20107:00 amRNSInterim Results
30th Jul 20107:00 amRNSTrading Update
7th Jul 201011:30 amRNSChange of name of adviser
2nd Jul 201011:30 amRNSIssue of Equity / Director Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.